Literature DB >> 12806245

Sputum cytology for the detection of early lung cancer.

Thomas L Petty1.   

Abstract

Sputum cytology is an important step in the early diagnosis of roentgenographically occult lung cancer. It identifies primarily intraepithelial lesions, which are the most common squamous carcinomas not detected by helical CT. Patients at highest risk for lung cancer (eg, heavy smokers with airflow obstruction) should undergo sputum cytology. Patients with premalignant lesions (eg, moderate or severe dysplasia) and of course patients with carcinoma in situ or invasive carcinoma should receive fiberoptic bronchoscopy. The diagnosis and treatment of early-stage lung cancer usually has a favorable outcome. Today we have the knowledge and technology that can change the outcome of lung cancer through early identification, particularly in high-risk patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12806245     DOI: 10.1097/00063198-200307000-00011

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  7 in total

Review 1.  Interphase cytogenetics of sputum cells for the early detection of lung carcinogenesis.

Authors:  Sheila A Prindiville; Thomas Ried
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-23

2.  Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease.

Authors:  Tanyalak Parimon; Jason W Chien; Chris L Bryson; Mary B McDonell; Edmunds M Udris; David H Au
Journal:  Am J Respir Crit Care Med       Date:  2006-12-21       Impact factor: 21.405

3.  Preliminary Results of NGS Gene Panel Test Using NSCLC Sputum Cytology and Therapeutic Effect Using Corresponding Molecular-Targeted Drugs.

Authors:  Kei Morikawa; Kohei Kinoshita; Hirotaka Kida; Takeo Inoue; Masamichi Mineshita
Journal:  Genes (Basel)       Date:  2022-05-02       Impact factor: 4.141

4.  Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study.

Authors:  V Paul Doria-Rose; Pamela M Marcus; Eva Szabo; Melvyn S Tockman; Myron R Melamed; Philip C Prorok
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

5.  3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).

Authors:  Sai Yendamuri; Ara A Vaporciyan; Tanweer Zaidi; Lei Feng; Ricardo Fernandez; Nebiyou B Bekele; Wayne L Hofstetter; Feng Jiang; Reza J Mehran; David C Rice; Margaret R Spitz; Stephen G Swisher; Garrett L Walsh; Jack A Roth; Ruth L Katz
Journal:  J Thorac Oncol       Date:  2008-09       Impact factor: 15.609

6.  Analysis for the mechanism between the small cell lung cancer and non-small cell lung cancer combing the miRNA and mRNA expression profiles.

Authors:  Weisan Zhang; Qiang Zhang; Mingpeng Zhang; Yun Zhang; Fengtan Li; Ping Lei
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

7.  Premalignant lesions as targets for cancer vaccines.

Authors:  Olivera J Finn
Journal:  J Exp Med       Date:  2003-11-24       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.